Table 4.
Previous therapy history of biological DMARDs.
| Patient | Gender | Age | Ocular inflammation | ADA | IFX | ETN | RTX | GOL | CER | ABA | TCZ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Female | 59 | Keratitis | NA | NA | NA | NA | NA | NA | + | NA |
| 2 | Female | 45 | Anterior and intermediate uveitis | + | + | NA | NA | NA | + | NA | NA |
| 3 | Female | 40 | Scleritis | NA | NA | NA | NA | NA | NA | NA | NA |
| 4 | Female | 22 | Anterior uveitis | + | + | NA | + | + | NA | NA | + |
| 5 | Female | 45 | Scleritis | + | NA | + | + | NA | NA | NA | + |
| 6 | Female | 43 | Panuveitis | + | + | NA | + | NA | NA | + | + |
| 7 | Female | 18 | Panuveitis | + | + | NA | + | NA | NA | + | NA |
| 8 | Female | 37 | Anterior uveitis | + | + | NA | NA | + | NA | NA | + |
| 9 | Male | 21 | Panuveitis | + | + | + | + | NA | NA | + | + |
| 10 | Male | 65 | Scleritis | NA | NA | NA | NA | NA | NA | NA | NA |
| 11 | Male | 43 | Conjunctivitis | + | NA | NA | + | NA | NA | NA | NA |
Notes: ADA: adalimumab; IFX: infliximab; ETN: etanercept; RTX: rituximab; GOL: golimumab; CER, certolizumab pegol; ABA: abatacept; TCZ: tocilizumab; NA: not available.